World Investment Advisors Boosts Position in Agilent Technologies, Inc. $A

World Investment Advisors raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 18.9% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,574 shares of the medical research company’s stock after buying an additional 886 shares during the quarter. World Investment Advisors’ holdings in Agilent Technologies were worth $658,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Stone House Investment Management LLC purchased a new position in Agilent Technologies during the 1st quarter valued at about $30,000. Ransom Advisory Ltd purchased a new position in Agilent Technologies during the 1st quarter valued at about $32,000. Central Pacific Bank Trust Division purchased a new position in Agilent Technologies during the 2nd quarter valued at about $33,000. Zions Bancorporation National Association UT purchased a new position in Agilent Technologies during the 1st quarter valued at about $38,000. Finally, Costello Asset Management INC bought a new stake in shares of Agilent Technologies during the 1st quarter valued at about $47,000. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Agilent Technologies Stock Performance

NYSE:A opened at $146.63 on Monday. The business has a 50 day moving average of $132.98 and a 200 day moving average of $121.01. The company has a market capitalization of $41.57 billion, a price-to-earnings ratio of 34.42, a PEG ratio of 4.67 and a beta of 1.26. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.Agilent Technologies’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th were given a $0.248 dividend. The ex-dividend date was Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s payout ratio is presently 23.24%.

Analyst Upgrades and Downgrades

A has been the subject of a number of research analyst reports. UBS Group upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and lifted their price target for the company from $130.00 to $170.00 in a research report on Wednesday, October 8th. TD Cowen lifted their price target on Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. Robert W. Baird lifted their price target on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research report on Thursday, August 28th. Wells Fargo & Company lifted their price target on Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research report on Monday, September 15th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $149.62.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.